NTT Data Corporation spent 20.5 billion Japanese yen on research and development (R&D) in fiscal year 2023, which was a decrease of more than four billion yen compared to the previous fiscal year. The company provides integrated IT solutions, system and software development, as well as consulting and maintenance support.

Expenditures on research and development (R&D) by performing sectors. This table is included in Section D: Postsecondary education: Research and development of the Pan Canadian Education Indicators Program (PCEIP). PCEIP draws from a wide variety of data sources to provide information on the school-age population, elementary, secondary and postsecondary education, transitions, education finance and labour market outcomes. The program presents indicators for all of Canada, the provinces, the territories, as well as selected international comparisons and comparisons over time. PCEIP is an ongoing initiative of the Canadian Education Statistics Council, a partnership between Statistics Canada and the Council of Ministers of Education, Canada that provides a set of statistical measures on education systems in Canada.

Russia Research and Development (R&D) Expenditure: OKVED2 data was reported at 1,020,188,455.400 RUB th in Sep 2022. This records an increase from the previous number of 627,892,545.300 RUB th for Jun 2022. Russia Research and Development (R&D) Expenditure: OKVED2 data is updated quarterly, averaging 848,886,509.500 RUB th from Sep 2019 (Median) to Sep 2022, with 13 observations. The data reached an all-time high of 1,591,951,259.300 RUB th in Dec 2021 and a record low of 213,915,749.000 RUB th in Mar 2020. Russia Research and Development (R&D) Expenditure: OKVED2 data remains active status in CEIC and is reported by Federal State Statistics Service. The data is categorized under Russia Premium Database’s Investment – Table RU.OD036: Research and Development Expenditure of Enterprises. [COVID-19-IMPACT]

United States US: Government Intramural Expenditure on R&D (GOVERD) data was reported at 75.823 USD bn in 2023. This records an increase from the previous number of 73.443 USD bn for 2022. United States US: Government Intramural Expenditure on R&D (GOVERD) data is updated yearly, averaging 35.945 USD bn from Dec 1981 (Median) to 2023, with 43 observations. The data reached an all-time high of 75.823 USD bn in 2023 and a record low of 13.455 USD bn in 1981. United States US: Government Intramural Expenditure on R&D (GOVERD) data remains active status in CEIC and is reported by Organisation for Economic Co-operation and Development. The data is categorized under Global Database’s United States – Table US.OECD.MSTI: Gross Domestic Expenditure on Research and Development: OECD Member: Annual.

For the United States, some respondents revised their reporting practices and eliminated expenditures that did not meet the definition of R&D during the 2023 BERD data collection. This has resulted in a meaningful decrease in estimated U.S. R&D performance compared to the amount of 2023 R&D performance that would have been estimated based on respondent reporting practices used in 2022 and earlier..From 2021 onwards, changes to the US BERD survey questionnaire allowed for more exhaustive identification of acquisition costs for ‘identifiable intangible assets’ used for R&D. This has resulted in a substantial increase in reported R&D capital expenditure within BERD. In the business sector, the funds from the rest of the world previously included in the business-financed BERD, are available separately from 2008. From 2006 onwards, GOVERD includes state government intramural performance (most of which being financed by the federal government and state government own funds). From 2016 onwards, PNPERD data are based on a new R&D performer survey. In the higher education sector all fields of SSH are included from 2003 onwards.

Following a survey of federally-funded research and development centers (FFRDCs) in 2005, it was concluded that FFRDC R&D belongs in the government sector - rather than the sector of the FFRDC administrator, as had been reported in the past. R&D expenditures by FFRDCs were reclassified from the other three R&D performing sectors to the Government sector; previously published data were revised accordingly. Between 2003 and 2004, the method used to classify data by industry has been revised. This particularly affects the ISIC category “wholesale trade” and consequently the BERD for total services.

U.S. R&D data are generally comparable, but there are some areas of underestimation:

1. i) Up to 2008, Government sector R&D performance covers only federal government activities. That by State and local government establishments is excluded;
2. ii) Except for the Government and the Business Enterprise sectors, the R&D data exclude most capital expenditures. For the Business Enterprise sector, depreciation is reported in place of gross capital expenditures up to 2014. Higher education (and national total) data were revised back to 1998 due to an improved methodology that corrects for double-counting of R&D funds passed between institutions.

Breakdown by type of R&D (basic research, applied research, etc.) was also revised back to 1998 in the business enterprise and higher education sectors due to improved estimation procedures.

The methodology for estimating researchers was changed as of 1985. In the Government, Higher Education and PNP sectors the data since then refer to employed doctoral scientists and engineers who report their primary work activity as research, development or the management of R&D, plus, for the Higher Education sector, the number of full-time equivalent graduate students with research assistantships averaging an estimated 50 % of their time engaged in R&D activities. As of 1985 researchers in the Government sector exclude military personnel. As of 1987, Higher education R&D personnel also include those who report their primary work activity as design.

Due to lack of official data for the different employment sectors, the total researchers figure is an OECD estimate up to 2021. As of 2022, it is based on official personnel data available for all sectors. For years 2020 and 2021, it is based on official personnel data available for the business, PNP and Higher Education sectors, and OECD estimates for the Government sector (for estimating the missing FFRDC component). For previous years, OECD estimates were readjusted back to 2000.

The government personnel data includes the state government R&D personnel from 2021 and FFRDC R&D personnel from 2022. However, 8 FFRDC centres are not included as they could not report their R&D personnel data. These 8 centres account for 24% of the total R&D expenditure of all FFRDCs in 2022. Pre-production development is excluded from Defence GBARD (in accordance with the Frascati Manual) as of 2000. 2009 GBARD data also includes the one time incremental R&D funding legislated in the American Recovery and Reinvestment Act of 2009. Beginning with the 2000 GBARD data, budgets for capital expenditure – “R&D plant” in national terminology - are included. GBARD data for earlier years relate to budgets for current costs only.

This repository contains GRAPE - the WUR-ERS Global Research on Agriculture: Personnel & Expenditures database that presents international comparable data on the number of public agricultural researchers and R&D expenditures for 190 countries, broadly covering the period 1960-2022. More information on the construction of GRAPE can be found in an accompanying article: Van Dijk, M. et al. (2025), A global database of public agricultural R&D investment: 1960-2022, https://doi.org/10.21203/rs.3.rs-6463998/v1

Graph and download economic data for Food and Beverage and Tobacco Products: Contribution of Research and Development (R&D) Intensity to Labor Productivity (MPU5500193) from 1988 to 2023 about R&D, tobacco, contributions, productivity, beverages, nondurable goods, food, production, goods, manufacturing, rate, and USA.

Researchers in R&D (per million people) in Vietnam was reported at 768 in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. Vietnam - Researchers in R&D (per million people) - actual values, historical data, forecasts and projections were sourced from the World Bank on May of 2025.

Researchers in R&D (per million people) in United States was reported at 4825 in 2021, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Researchers in R&D (per million people) - actual values, historical data, forecasts and projections were sourced from the World Bank on May of 2025.

Researchers in R&D (per million people) in Denmark was reported at 8736 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Denmark - Researchers in R&D (per million people) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

Expenditure on Research and Development(R&D) by countries with indicators such as source of funds, type of R%&D activity, fields of R&D(medical and health sciences) since 1996.

Data comes from U...

Hong Kong Research and Development (R&D) Expenditure data was reported at 19,713.100 HKD mn in 2016. This records an increase from the previous number of 18,270.700 HKD mn for 2015. Hong Kong Research and Development (R&D) Expenditure data is updated yearly, averaging 12,293.200 HKD mn from Dec 1998 (Median) to 2016, with 19 observations. The data reached an all-time high of 19,713.100 HKD mn in 2016 and a record low of 5,602.500 HKD mn in 1998. Hong Kong Research and Development (R&D) Expenditure data remains active status in CEIC and is reported by Census and Statistics Department. The data is categorized under Global Database’s Hong Kong SAR – Table HK.S004: Innovation Activities Statistics.

Researchers in R&D (per million people) in Italy was reported at 2796 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Italy - Researchers in R&D (per million people) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

Researchers in R&D (per million people) in Luxembourg was reported at 4879 in 2022, according to the World Bank collection of development indicators, compiled from officially recognized sources. Luxembourg - Researchers in R&D (per million people) - actual values, historical data, forecasts and projections were sourced from the World Bank on June of 2025.

In 2023, research and development spending in the pharmaceutical industry exceeded 300 billion U.S. dollars globally. For comparison, R&D expenditures totaled 137 billion dollars in 2012. Pharmaceutical R&D includes all steps from the initial research of disease processes, the compound testing over pre-clinical, and all clinical trial stages. At a certain point in the process – mostly during the pre-clinical phase – a governmental authority is involved to overview, regulate, and ultimately approve the drug. In the United States, the Food and Drug Administration is the principal agency associated with processes. The pressure to innovate In comparison to other industries, pharmaceutical companies are more driven by the imperative to manufacture innovative products, and thus to spend significant amounts on research and development. This is largely due to the time-limited patent protection of drugs and the following threat of sales erosion through generic and biosimilar competition. Two major effects of patent expirations for the pharma industry are a specific high R&D intensity and a growing focus on specialty drugs to diversify their product portfolio. The latest trends For the last several years, major developments in pharmaceutical research and development have begun to change the R&D landscape. A growing number of drug manufacturers are outsourcing large parts of R&D, mostly to clinical research organizations (also contract research organizations), with the main aim to reduce costs. Another important development is the use of big data in clinical research. Thus, a predictive modeling is possible which uses clinical and molecular data to develop safer and more efficient drugs. Particularly, real-time or real-world evidence (RWE) is becoming a greater interest. This makes cooperation with technology companies necessary and includes data gathered from various sources, even that of social media.

The Industrial R&D Investment Scoreboard (IRI) is a scientific project carried out within the Directorate B of Growth and Innovation, one of the seven scientific institutes of the European Commission's Joint Research Centre (JRC). 'iriR' 's objective is to allow an easy connection with R to the European Commission's Economics of Industrial Research and Innovation data.

Historical dataset from OECD on R&D and Innovation indicators.Source : Data extracted from OECD Database.Use : Was used to study, and analyse innovation management indicators for industries across Countries with such available data. These set of data of R&D indicators or measures(expenditure, personnel) was to investigate innovation management using Data Analysis and applying Machine Learning Algorithm for data prediction.To Use : For each Excel file, see description and meanings of parameters in "Notes" tab.Furthermore, for the specific R&D Expenditures and Personnel links :R&D Expenditure: Business enterprise R&D expenditure by industryR&D Personnel: R&D personnel by sector of employment and function

Graph and download economic data for Expenses for Research and Development In The Physical, Engineering, and Life Sciences, All Establishments, Employer Firms (RADITPEALSE3154171) from 2003 to 2022 about R&D, engineering, science, life, employer firms, establishments, expenditures, and USA.

Forecast: Business Enterprise R&D Expenditure in Data Processing, Hosting and Related Activities; Web Portals in Japan 2024 - 2028 Discover more data with ReportLinker!

In this presentation, Monia discusses innovation and provides definitions for the concepts, players and measures relating to R&D. She also introduces us to two new components of the business statistical system: the General Business Panel Survey (GBPS) and the Integrated Business Database (IBD).

This dataset contains information about hundreds of designated user-facilities and R&D equipment funded by the U.S. Department of Energy and accessible to the private sector. These facilities reside at DOE's National Laboratories throughout the United States and are meant to advance scientific research and accelerated technology commercialization.